A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor ...
May 14, 2020
0
35
To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease. Researchers at Lund University in Sweden ...
Mar 25, 2020
0
2
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.
Jun 25, 2019
0
0
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer ...
Jun 25, 2019
0
2
Research presented at the Society of Nuclear Medicine and Molecular Imaging's 2019 Annual Meeting shows that molecular imaging with 18F-FDG positron emission tomography/computed tomography (PET/CT) can evaluate tuberculosis ...
Jun 24, 2019
0
0
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of ...
Jun 24, 2019
0
0
Scientists have reported an advanced imaging technique that allows the condition of joint cartilage to be examined—right down to the molecular level. The technique has potential for diagnostics and treatment-planning of ...
Mar 14, 2019
0
18
ANSTO's unique capabilities and expertise in the production and application of radiotracers for imaging have been highlighted in a recent publication in the journal Theranostics.
Dec 04, 2018
0
0
USC researchers have identified biomarkers associated with severe birth defects in babies born to women infected with the Zika virus, a discovery that could lead to screening tests and a better understanding about how the ...
Nov 02, 2018
0
30
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to radionuclide therapy targeting prostate specific membrane antigen (PSMA) with the radionuclide lutetium-177 ...
Jun 27, 2018
0
2
